Cargando…
B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242264/ http://dx.doi.org/10.1186/1479-5876-9-S2-P36 |
| _version_ | 1782219615080808448 |
|---|---|
| author | Thiel, Jens Effelsberg, Nora M Warnatz, Klaus Schlesier, Michael Peter, Hans Hartmut Voll, Reinhard E Venhoff, Nils |
| author_facet | Thiel, Jens Effelsberg, Nora M Warnatz, Klaus Schlesier, Michael Peter, Hans Hartmut Voll, Reinhard E Venhoff, Nils |
| author_sort | Thiel, Jens |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3242264 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32422642011-12-19 B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide Thiel, Jens Effelsberg, Nora M Warnatz, Klaus Schlesier, Michael Peter, Hans Hartmut Voll, Reinhard E Venhoff, Nils J Transl Med Poster Presentation BioMed Central 2011-11-23 /pmc/articles/PMC3242264/ http://dx.doi.org/10.1186/1479-5876-9-S2-P36 Text en Copyright ©2011 Thiel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Thiel, Jens Effelsberg, Nora M Warnatz, Klaus Schlesier, Michael Peter, Hans Hartmut Voll, Reinhard E Venhoff, Nils B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide |
| title | B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide |
| title_full | B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide |
| title_fullStr | B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide |
| title_full_unstemmed | B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide |
| title_short | B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide |
| title_sort | b cell depletion by rituximab severely reduces immunoglobulin levels in patients with anca-associated vasculitis previously treated with cyclophosphamide |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242264/ http://dx.doi.org/10.1186/1479-5876-9-S2-P36 |
| work_keys_str_mv | AT thieljens bcelldepletionbyrituximabseverelyreducesimmunoglobulinlevelsinpatientswithancaassociatedvasculitispreviouslytreatedwithcyclophosphamide AT effelsbergnoram bcelldepletionbyrituximabseverelyreducesimmunoglobulinlevelsinpatientswithancaassociatedvasculitispreviouslytreatedwithcyclophosphamide AT warnatzklaus bcelldepletionbyrituximabseverelyreducesimmunoglobulinlevelsinpatientswithancaassociatedvasculitispreviouslytreatedwithcyclophosphamide AT schlesiermichael bcelldepletionbyrituximabseverelyreducesimmunoglobulinlevelsinpatientswithancaassociatedvasculitispreviouslytreatedwithcyclophosphamide AT peterhanshartmut bcelldepletionbyrituximabseverelyreducesimmunoglobulinlevelsinpatientswithancaassociatedvasculitispreviouslytreatedwithcyclophosphamide AT vollreinharde bcelldepletionbyrituximabseverelyreducesimmunoglobulinlevelsinpatientswithancaassociatedvasculitispreviouslytreatedwithcyclophosphamide AT venhoffnils bcelldepletionbyrituximabseverelyreducesimmunoglobulinlevelsinpatientswithancaassociatedvasculitispreviouslytreatedwithcyclophosphamide |